A case of acute transverse myelitis following the AstraZeneca COVID-19 vaccine
Main Article Content
Downloads
Article Details
Copyright (c) 2023 Madike R, et al.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Medicines and Healthcare Products Regulatory Agency (MHRA). Regulatory approval of Vaxzevria (previously COVID-19 Vaccine AstraZeneca) 2020 [updated 19 July, 2021. https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca#history.
Malhotra HS, Gupta P, Prabhu V, Kumar Garg R, Dandu H, Agarwal V. COVID-19 vaccination-associated myelitis. QJM. 2021 Nov 5;114(8):591-593. doi: 10.1093/qjmed/hcab069. PMID: 33787891; PMCID: PMC8083508.
Piroth L, Cottenet J, Mariet AS, Bonniaud P, Blot M, Tubert-Bitter P, Quantin C. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med. 2021 Mar;9(3):251-259. doi: 10.1016/S2213-2600(20)30527-0. Epub 2020 Dec 17. PMID: 33341155; PMCID: PMC7832247.
Department of Health. ATAGI statement regarding COVID-19 vaccines in the setting of transmission of the Delta variant of concern: Commonwealth of Australia; 2021. https://www.health.gov.au/news/atagi-statement-regarding-covid-19-vaccines-in-the-setting-of-transmission-of-the-delta-variant-of-concern.
Cattaneo M. Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines. Eur J Intern Med. 2021 Jul;89:22-24. doi: 10.1016/j.ejim.2021.05.031. Epub 2021 May 25. PMID: 34092488; PMCID: PMC8148431.